Evidence map›Paper›PMID 27151989›Full record

ArticleHaematologica2016

Deletions of the long arm of chromosome 5 define subgroups of T-cell acute lymphoblastic leukemia.

Roberta La Starza, Gianluca Barba, Sofie Demeyer, Valentina Pierini, Danika Di Giacomo, Valentina Gianfelici, Claire Schwab, Caterina Matteucci, Carmen Vicente, Jan Cools and 7 more

Open access · goldAbstract read
In one paragraph

Article in Haematologica, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. RecurrentHemaSphere · 2021
    Article
  9. Review
  10. Review
  11. Nucleophosmin in Its Interaction with Ligands.International journal of molecular sciences · 2020
    Review
  12. Article
  13. Article
  14. American journal of blood research · 2020
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 3 countries.

Roberta La StarzaMolecular Medicine Laboratory, Center for Hemato-Oncology Research, University of Perugia, Italy.
Gianluca BarbaMolecular Medicine Laboratory, Center for Hemato-Oncology Research, University of Perugia, Italy.
Sofie DemeyerCenter for Human Genetics, KU Leuven, Belgium Center for the Biology of Disease, VIB, Leuven, Belgium.
Valentina PieriniMolecular Medicine Laboratory, Center for Hemato-Oncology Research, University of Perugia, Italy.
Danika Di GiacomoMolecular Medicine Laboratory, Center for Hemato-Oncology Research, University of Perugia, Italy.
Valentina GianfeliciHematology, Department of Cellular Biotechnologies and Hematology, "Sapienza" University, Rome, Italy.
Claire SchwabLeukaemia Research Cytogenetic Group, Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UK.
Caterina MatteucciMolecular Medicine Laboratory, Center for Hemato-Oncology Research, University of Perugia, Italy.
Carmen VicenteCenter for Human Genetics, KU Leuven, Belgium Center for the Biology of Disease, VIB, Leuven, Belgium.
Jan CoolsCenter for Human Genetics, KU Leuven, Belgium Center for the Biology of Disease, VIB, Leuven, Belgium.
Monica MessinaHematology, Department of Cellular Biotechnologies and Hematology, "Sapienza" University, Rome, Italy.
Barbara CrescenziMolecular Medicine Laboratory, Center for Hemato-Oncology Research, University of Perugia, Italy.
Sabina ChiarettiHematology, Department of Cellular Biotechnologies and Hematology, "Sapienza" University, Rome, Italy.
Robin FoàHematology, Department of Cellular Biotechnologies and Hematology, "Sapienza" University, Rome, Italy.
Giuseppe BassoPediatric Hemato-Oncology, Department of Pediatrics "Salus Pueri", University of Padova, Italy.
Christine J HarrisonLeukaemia Research Cytogenetic Group, Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UK.
Cristina MecucciMolecular Medicine Laboratory, Center for Hemato-Oncology Research, University of Perugia, Italy cristina.mecucci@unipg.it.
University of Perugia · ITSapienza University of Rome · ITVIB-KU Leuven Center for Cancer Biology · BENewcastle University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recurrent deletions of the long arm of chromosome 5 were detected in 23/200 cases of T-cell acute lymphoblastic leukemia. Genomic studies identified two types of deletions: interstitial and terminal. Interstitial 5q deletions, found in five cases, were present in both adults and children with a female predominance (chi-square, P=0.012). Interestingly, these cases resembled immature/early T-cell precursor acute lymphoblastic leukemia showing significant down-regulation of five out of the ten top differentially expressed genes in this leukemia group, including TCF7 which maps within the 5q31 common deleted region. Mutations of genes known to be associated with immature/early T-cell precursor acute lymphoblastic leukemia, i.e. WT1, ETV6, JAK1, JAK3, and RUNX1, were present, while CDKN2A/B deletions/mutations were never detected. All patients had relapsed/resistant disease and blasts showed an early differentiation arrest with expression of myeloid markers. Terminal 5q deletions, found in 18 of patients, were more prevalent in adults (chi-square, P=0.010) and defined a subgroup of HOXA-positive T-cell acute lymphoblastic leukemia characterized by 130 up- and 197 down-regulated genes. Down-regulated genes included TRIM41, ZFP62, MAPK9, MGAT1, and CNOT6, all mapping within the 1.4 Mb common deleted region at 5q35.3. Of interest, besides CNOT6 down-regulation, these cases also showed low BTG1 expression and a high incidence of CNOT3 mutations, suggesting that the CCR4-NOT complex plays a crucial role in the pathogenesis of HOXA-positive T-cell acute lymphoblastic leukemia with terminal 5q deletions. In conclusion, interstitial and terminal 5q deletions are recurrent genomic losses identifying distinct subtypes of T-cell acute lymphoblastic leukemia.

Indexed as

Chromosome DeletionChromosomes, Human, Pair 5AdolescentAdultBiomarkersChildCohort StudiesFemaleGene Expression ProfilingGenetic Association StudiesHomeodomain ProteinsHumansImmunophenotypingMaleMiddle AgedPhenotypeBiomarkersHomeodomain ProteinsHoxA protein

Identifiers

PMID27151989
PMCPMC4967574
OpenAlexW2345418755

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.